Home › Cancro alla prostata › Colorado › Colorado Springs
Studi clinici su Cancro alla prostata a Colorado Springs, CO
12 studi su Cancro alla prostata cercano partecipanti presso sedi a Colorado Springs e dintorni (entro circa 30 miglia). Apri uno studio per vedere chi può partecipare e come contattare il team.
Testo ufficiale dello studio (inglese)
Stai reclutando per uno studio? Mettilo in evidenza in cima alla pagina — $99 per 30 giorni →
Testing Different Dosing Schedules of the Anti-cancer Drug, Lutetium 177Lu PSMA RLT and Its Effect on Patients With Advanced Prostate Cancer, RECIPROCAL Trial
In reclutamentoFase 3
- UCHealth Memorial Hospital Central, Colorado Springs
- Memorial Hospital North, Colorado Springs
Targeted Treatment for Metastatic Prostate Cancer, The PREDICT Trial
In reclutamentoFase 2
- UCHealth Memorial Hospital Central, Colorado Springs
- Memorial Hospital North, Colorado Springs
Collecting Blood Samples From Patients With and Without Cancer to Evaluate Tests for Early Cancer Detection
In reclutamentoStudio osservazionaleVolontari sani benvenuti
- Penrose-Saint Francis Healthcare, Colorado Springs
- Rocky Mountain Cancer Centers-Penrose, Colorado Springs
- Saint Francis Cancer Center, Colorado Springs
Study of HLD-0915 (JNJ-101556143) in Patients With Metastatic Prostate Cancer
In reclutamentoFase 1/2
- Rocky Mountain Cancer Center, Colorado Springs
Testing Shorter Duration Radiation Therapy Versus the Usual Radiation Therapy in Patients With High Risk Prostate Cancer
In reclutamentoFase 3
- Rocky Mountain Cancer Centers-Penrose, Colorado Springs
- UCHealth Memorial Hospital Central, Colorado Springs
- Memorial Hospital North, Colorado Springs
Study of Oral MRT-2359 With Apalutamide in Prostate Cancer
In reclutamentoFase 2
- Rocky Mountain Cancer Center, Colorado Springs
Treating Prostate Cancer That Has Come Back After Surgery With Apalutamide and Targeted Radiation Based on PET Imaging
In reclutamentoFase 3
- Penrose-Saint Francis Healthcare, Colorado Springs
- Rocky Mountain Cancer Centers-Penrose, Colorado Springs
- Saint Francis Cancer Center, Colorado Springs
Docetaxel to Androgen Receptor Pathway Inhibitors in Patients With Metastatic Castration Sensitive Prostate Cancer and Suboptimal PSA Response
In reclutamentoFase 3
- Penrose-Saint Francis Healthcare, Colorado Springs
- Rocky Mountain Cancer Centers-Penrose, Colorado Springs
- UCHealth Memorial Hospital Central, Colorado Springs
- e altri 2
Study of ORIC-944 in Patients With Metastatic Prostate Cancer
In reclutamentoFase 1
- Rocky Mountain Cancer Center, Colorado Springs
Pragmatic Trial of Metformin for Glucose Intolerance or Increased BMI in Prostate Cancer Patients
In reclutamentoFase 1 iniziale
- UCHealth-Southern Colorado, Colorado Springs
Carboplatin Chemotherapy Before Surgery for People With High-Risk Prostate Cancer and an Inherited BRCA1 or BRCA2 Gene Mutation
In reclutamentoFase 2
- Penrose-Saint Francis Healthcare, Colorado Springs
- Rocky Mountain Cancer Centers-Penrose, Colorado Springs
- Saint Francis Cancer Center, Colorado Springs
Standard Systemic Therapy With or Without Definitive Treatment in Treating Participants With Metastatic Prostate Cancer
In reclutamentoFase 3
- UCHealth Memorial Hospital Central, Colorado Springs
- Memorial Hospital North, Colorado Springs
Studi su Cancro alla prostata in altre città
- New York City, NY103 studi
- Houston, TX76 studi
- Los Angeles, CA61 studi
- Boston, MA59 studi
- St. Louis, MO46 studi
- Chicago, IL45 studi
- San Francisco, CA45 studi
- Philadelphia, PA44 studi
- Baltimore, MD43 studi
- Nashville, TN43 studi
- Seattle, WA42 studi
- Washington, DC38 studi
Altri studi a Colorado Springs
- Colite ulcerosa14 studi
- Malattia di Crohn13 studi
- Cancro del polmone non a piccole cellule11 studi
- Cancro ai polmoni8 studi
- Cancro al seno7 studi
- Asma6 studi
- Cancro del colon6 studi
- Cancro colorettale6 studi
- Cancro del retto4 studi
- Disturbi della sonnolenza eccessiva4 studi
- Malattia infiammatoria intestinale4 studi
- Carcinoma a cellule squamose della testa e del collo4 studi
Fonte: ClinicalTrials.gov, dati recuperati il 6 ott 2026. Ogni studio stabilisce i propri criteri di idoneità; è il team di ricerca a decidere chi può partecipare.